journal article·2018-10-12Open access

Development and Evaluation of an Injectable Chitosan/β-Glycerophosphate Paste as a Local Antibiotic Delivery System for Trauma Care

Logan Boles, Christopher Alexander, Leslie Pace, Warren Haggard, Joel Bumgardner, Jessica Jennings

Abstract

Complex open musculoskeletal wounds are a leading cause of morbidity worldwide, partially due to a high risk of bacterial contamination. Local delivery systems may be used as adjunctive therapies to prevent infection, but they may be nondegradable, possess inadequate wound coverage, or migrate from the wound site. To address this issue, a thermo-responsive, injectable chitosan paste was fabricated by incorporating beta-glycerophosphate. The efficacy of thermo-paste as an adjunctive infection prevention tool was evaluated in terms of cytocompatibility, degradation, antibacterial, injectability, and inflammation properties. In vitro studies demonstrated thermo-paste may be loaded with amikacin and vancomycin and release inhibitory levels for at least 3 days. Further, approximately 60% of thermo-paste was enzymatically degraded within 7 days in vitro. The viability of cells exposed to thermo-paste exceeded ISO 10993-5 standards with approximately 73% relative viability of a control chitosan sponge. The ejection force of thermo-paste, approximately 20 N, was lower than previously studied paste formulations and within relevant clinical ejection force ranges. An in vivo murine biocompatibility study demonstrated that thermo-paste induced minimal inflammation after implantation for 7 days, similar to previously developed chitosan pastes. Results from these preliminary preclinical studies indicate that thermo-paste shows promise for further development as an antibiotic delivery system for infection prevention.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Wound Healing and Treatments · Antimicrobial agents and applications · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering, University of Memphis, Memphis, TN 38152, USA

Funding

National Institutes of Health

References (42)

Show source-provided references
1. Complex wounds and their management
2. The global burden of injuries10.2105/AJPH.90.4.523 ↗
3. Role of systemic and local antibiotics in the treatment of open fractures
4. Acute management of open fractures: An evidence-based review10.3928/01477447-20151020-12 ↗
5. The clinical impact of bacterial biofilms10.4248/IJOS11026 ↗
6. Bacterial biofilms and periprosthetic infections
7. What’s new in musculoskeletal infection: Update on biofilms10.2106/JBJS.16.00300 ↗
8. Antimicrobial delivery systems for local infection prophylaxis in orthopedic-and trauma surgery10.1016/j.biomaterials.2015.02.020 ↗
9. Chitin and chitosan: Properties and applications10.1016/j.progpolymsci.2006.06.001 ↗
10. Biomaterials approaches to treating implant-associated osteomyelitis10.1016/j.biomaterials.2015.12.012 ↗
11. Applications of local antibiotics in orthopedic trauma
12. Calcium sulfates: What is the evidence?10.1097/BOT.0b013e3181cec48e ↗
13. Chitin and chitosan preparation from marine sources. Structure, properties and applications10.3390/md13031133 ↗
14. Evaluation of the biocompatibility of a chitosan scaffold in mice10.1002/jbm.1270 ↗
15. Chitosan—A versatile semi-synthetic polymer in biomedical applications10.1016/j.progpolymsci.2011.02.001 ↗
16. Synthesis and characterisation of photocrosslinked poly(ethylene glycol) diacrylate implants for sustained ocular drug delivery10.1007/s11095-017-2298-9 ↗
17. Characterization of local delivery with amphotericin b and vancomycin from modified chitosan sponges and functional biofilm prevention evaluation10.1002/jor.22760 ↗
18. Chitosan sponges to locally deliver amikacin and vancomycin: A pilot in vitro evaluation10.1007/s11999-010-1324-6 ↗
19. Local antibiotic delivery using tailorable chitosan sponges: The future of infection control?10.1097/BOT.0b013e3181ed296c ↗
20. Evaluation of a chitosan-polyethylene glycol paste as a local antibiotic delivery device10.5312/wjo.v8.i2.130 ↗
21. Blended chitosan paste for infection prevention: Preliminary and preclinical evaluations10.1007/s11999-017-5231-y ↗
22. Biocompatibility and gelation of chitosan–glycerol phosphate hydrogels10.1002/jbm.a.31676 ↗
23. Glycerophosphate-based chitosan thermosensitive hydrogels and their biomedical applications10.1016/j.carbpol.2014.09.094 ↗
24. ISO E. 10993-5 (2009). Biological Evaluation of Medical Devices. Part 5: Tests for In Vitro Cytotoxicity, International Organization for Standardization.
25. Preliminary evaluation of local drug delivery of amphotericin b and in vivo degradation of chitosan and polyethylene glycol blended sponges10.1002/jbm.b.33356 ↗
26. Characteristics and clinical assessment of antibiotic delivery by chitosan sponge in the high-risk diabetic foot: A case series10.12968/jowc.2017.26.Sup4.S32 ↗
27. Injectable thermosensitive chitosan hydrogels with controlled gelation kinetics and enhanced mechanical resistance10.1016/j.carbpol.2015.04.063 ↗
28. PEG-g-chitosan thermosensitive hydrogel for implant drug delivery: Cytotoxicity, in vivo degradation and drug release10.1080/09205063.2013.851542 ↗
29. Chitosan-peg hydrogel with sol–gel transition triggerable by multiple external stimuli10.1002/marc.201400586 ↗
30. Thermosensitive hydrogel for periodontal application: In vitro drug release, antibacterial activity and toxicity evaluation10.1177/0885328215614191 ↗
31. A critical review on polymer-based bio-engineered materials for scaffold development10.1016/j.compositesb.2006.06.014 ↗
32. Physical properties and in vitro evaluation of collagen–chitosan–calcium phosphate microparticle-based scaffolds for bone tissue regeneration10.1177/0885328212465662 ↗
33. Preparation and characterization of genipin cross-linked porous chitosan–collagen–gelatin scaffolds using chitosan—CO2 solution10.1016/j.carbpol.2013.10.060 ↗
34. Macrophages create an acidic extracellular hydrolytic compartment to digest aggregated lipoproteins10.1091/mbc.e09-07-0559 ↗
35. Grip type alters maximal pinch forces in syringe use10.1177/0018720817720339 ↗
36. Physical gelation of chitosan in the presence of β-glycerophosphate: The effect of temperature10.1021/bm050313s ↗
37. In vitro and in vivo evaluation of chitosan/β-glycerol phosphate composite membrane for guided bone regeneration10.1002/jbm.a.34874 ↗
38. Validated spectrofluorimetric method for determination of selected aminoglycosides10.1016/j.saa.2014.07.020 ↗
39. Global gene expression in Staphylococcus aureus biofilms10.1128/JB.186.14.4665-4684.2004 ↗
40. Cis-2-decenoic acid interacts with bacterial cell membranes to potentiate additive and synergistic responses against biofilm
41. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis10.1002/hep.1840010511 ↗
42. Preliminary investigation of crosslinked chitosan sponges for tailorable drug delivery and infection control10.1002/jbm.b.32822 ↗